We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Inpeco

Inpeco is a global leader in automation systems for clinical laboratories and designs cutting-edge solutions for both... read more Featured Products: More products

Download Mobile App





Inpeco Launches Next-Generation Total Lab Automation System

By LabMedica International staff writers
Posted on 01 Aug 2024
Print article
Image: The new FlexLab X total lab automation system unveiled at ADLM 2024 (Photo courtesy of Inpeco)
Image: The new FlexLab X total lab automation system unveiled at ADLM 2024 (Photo courtesy of Inpeco)

At ADLM 2024, Inpeco SA (Novazzano, Switzerland) is introducing FlexLab X, its new total lab automation system, to the global laboratory medicine community.

Set to redefine automation excellence, FlexLab X offers enhanced flexibility, a best-in-class user experience, and excellent performance. Open and flexible by design, FlexLab X allows labs to freely combine analyzers from different vendors, for optimal patient outcomes. Its standardized track components enable space-saving layouts tailored to a lab’s needs that scale easily in three dimensions, to support future growth. Offering sleek graphical user interfaces (GUI) and powerful Data Analytics functionalities, FlexLab X is intuitively easy to use and monitor. This simplifies daily work and helps eliminate errors, while KPI dashboards provide actionable insights to streamline workflows.

Thanks to its outstanding performance, FlexLab X assures rapid and consistent turnaround times (TAT) at all sample volume levels, and it supports premium-quality results that are fully traceable. Moreover, FlexLab X is designed to maximize uptime and reduce running costs, contributing to an attractive return on investment (ROI). Clinical laboratories benefit from safe and efficient workflows that get the daily routine done. Premium-quality results support improved patient outcomes, and the attractive return delivered by a FlexLab X investment helps labs to better cope with increasing budget pressures.

Related Links:
Inpeco SA

New
Gold Member
ANCA IFA
Kallestad Autoimmune ANCA IFA Complete Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
hCG+β Automated Immunofluorescent Assay
B·R·A·H·M·S hCG+β KRYPTOR
New
Adrenocorticotropic Hormone ELISA
ACTH ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The blood test analyzes 32 proteins to predict the risk for developing severe respiratory conditions (Photo courtesy of Adobe Stock)

Blood Test Predicts Risk for Developing COPD and Other Severe Respiratory Diseases

Chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), impact millions of adults worldwide and were the third leading cause of death in 2019. Major risk factors include smoking,... Read more

Hematology

view channel
Image: The new platelet-centric scoring system predicts platelet hyperreactivity and related risk of cardiovascular events (Photo courtesy of Shutterstock)

Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke

Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel

New Technology Holistically Images Deep Living Tissue for The First Time

Tissue engineering involves the restoration or enhancement of cell and tissue function in the body by replacing defective counterparts with lab-grown ones. This technique holds promise for a wide range of applications, such as cultivating cartilage to transplant into a patient's damaged knee. Since cartilage cannot regenerate... Read more

Industry

view channel
Image: Roche has expanded its digital pathology open environment with more than 20 AI algorithms (Photo courtesy of Roche)

Roche Expands Digital Pathology Open Environment with Integration of Advanced AI Algorithms from New Collaborators

Roche (Basel, Switzerland) has expanded its digital pathology open environment by integrating over 20 advanced artificial intelligence (AI) algorithms from eight new collaborators. These strategic collaborations... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.